10.2.3. Molecular Diagnosis

You know that for effective treatment of a disease, early diagnosis and understanding its pathophysiology is very important. Using conventional methods of diagnosis (serum and urine analysis, etc.) early detection is not possible.

Early diagnosis is crucial for the effective treatment of diseases. It allows healthcare providers to identify conditions before they advance, potentially making treatments more effective. Traditional diagnostic methods, such as serum and urine analysis, often fail to detect diseases in their early stages, which can be detrimental to patient health. By understanding the causes and mechanisms of diseases (pathophysiology), medical professionals can better tailor treatment plans to individual needs.

Think of early diagnosis like catching a leak in your house before it leads to a flood. If you spot the leak early, you can fix it quickly and prevent major water damage.

Recombinant DNA technology, Polymerase Chain Reaction (PCR), and Enzyme Linked Immuno-sorbent Assay (ELISA) are some of the techniques that serve the purpose of early diagnosis.

To improve early diagnosis, modern techniques such as Recombinant DNA technology, PCR, and ELISA are employed. These methods allow for more precise detection of pathogens at lower concentrations, making it possible to identify infections or diseases before symptoms arise. PCR, for instance, amplifies small segments of DNA, making it easier to identify even minor infections of viruses or bacteria.

Imagine trying to find a needle in a haystack. PCR acts like a magnet that draws the needle to the surface, allowing you to find it quickly and easily, even if it’s small and buried under lots of hay.

Presence of a pathogen (bacteria, viruses, etc.) is normally suspected only when the pathogen has produced a disease symptom. By this time the concentration of pathogen is already very high in the body.

Traditional diagnostic methods often rely on the symptoms exhibited by a patient to suspect the presence of pathogens. Unfortunately, by the time symptoms are noticeable, the quantity of pathogens within the body is usually quite high, complicating treatment and recovery. This highlights the need for techniques that can identify infection at much lower levels before symptoms are apparent.

It's like discovering a fire only after the flames are out of control. You would have wanted to detect the smoke or even the heat beforehand, much like how we want to identify an infection before it becomes serious.

However, very low concentration of a bacteria or virus (at a time when the symptoms of the disease are not yet visible) can be detected by amplification of their nucleic acid by PCR. Can you explain how PCR can detect very low amounts of DNA? PCR is now routinely used to detect HIV in suspected AIDS patients.

Polymerase Chain Reaction (PCR) is a technique that allows scientists to amplify (make many copies of) a specific segment of DNA. This is particularly useful for detecting pathogens at low concentrations, even before symptoms occur. In the case of HIV, PCR can identify the presence of the virus in patients by amplifying viral DNA, making it easier to diagnose the infection.

Consider PCR as a loudspeaker that amplifies a whisper: it can take a very quiet sound (low amounts of DNA) and turn it into a noise that everyone can hear (an easily detectable amount), thus allowing you to 'hear' even the faintest signals of an illness.

It is being used to detect mutations in genes in suspected cancer patients too. It is a powerful technique to identify many other genetic disorders.

Beyond infectious diseases, PCR is also a powerful tool for identifying genetic mutations associated with cancers and other genetic disorders. By amplifying regions of DNA that are known to harbor mutations, clinicians can diagnose conditions much earlier than traditional methods would allow.

Imagine a game of hide and seek where PCR is like a detective with a magnifying glass. Instead of waiting for someone to reveal themselves, the detective can look closely at every corner (gene) and find hidden secrets (mutations) that can lead to significant health insights.

A single stranded DNA or RNA, tagged with a radioactive molecule (probe) is allowed to hybridise to its complementary DNA in a clone of cells followed by detection using autoradiography. The clone having the mutated gene will hence not appear on the photographic film, because the probe will not have complementarity with the mutated gene.

Special DNA probes can be used to identify specific genetic sequences within cells. These probes bind to complementary sequences, and through autoradiography, they can reveal the presence of normal or mutated genes. If a mutation is present, the probe won't bind, and this lack of binding can be visualized on the film or screen, indicating a mutation in the gene.

This process is similar to using a key to open a lock. If the key (probe) doesn’t fit (bind) the lock (mutated gene), you won't be able to open that door and will know something is wrong.

ELISA is based on the principle of antigen-antibody interaction. Infection by pathogen can be detected by the presence of antigens (proteins, glycoproteins, etc.) or by detecting the antibodies synthesised against the pathogen.

Enzyme Linked Immuno-sorbent Assay (ELISA) is a test that detects the presence of specific antigens or antibodies in a sample. When a pathogen infects the body, it usually produces proteins (antigens). Conversely, the immune system produces antibodies in response to these antigens. ELISA uses this interaction to determine whether a person has been infected with a specific pathogen.

Think of ELISA as a security guard checking for identification badges. Just as the guard checks for the presence of badges (antibodies or antigens), ELISA checks biological samples for signs of infection, playing a critical role in disease diagnosis.

--